je.st
news
BioCryst snags $1.9M for antiviral candidate
2014-06-24 05:28:05| Biotech - Topix.net
The Durham-based company, which is developing an antiviral dubbed BCX4430, had already partnered with the National Institute of Allergy and Infectious Diseases, receiving an initial award of $5 million last September.
Tags: candidate
19m
antiviral
snags
Category:Biotechnology and Pharmaceuticals